Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Investigated for use/treatment in cardiac surgery.
- Mechanism
- Curator reviewed
Cariporide is a selective sodium-hydrogen antiporter inhibitor. The sodium-hydrogen exchanger is an importatn player in the pathophysiology of myocardial ischemia-referfusion injury. The accumulation of hydrogen ions in the myocyte cytoso; during ischemia creates a proton gradiant that promote the efflux of hydrogen ions in exchange for the influx of sodium ions. This sodium buildup can secondary activates the sodium-calcium exchanger to operate in the reverse mode, resulting in a net calcium accumulation in myocyte cytosol, which leads to dysfunction and cell death. By inhibiting sodium-hydrogen exchange, Cariporide can prevent the accumulation of calcium in cytosol, therefore reduce the infarct size.
- Primary indication
- Investigated for use/treatment in cardiac surgery.Curator reviewed
- Formula / weight
- C12H17N3O3S · 283.35 g/mol (avg)
Resolves to
IWXNYAIICFKCTM-UHFFFAOYSA-NSMILESCC(C)C1=CC=C(C=C1S(C)(=O)=O)C(=O)NC(N)=NWhat you can answer from here — as of September 20, 2026
Which drugs share a target with Cariporide, and which of those have an active Phase 3 trial?